Jefferies Cuts Price Target on Dollar Tree (DLTR) Following 2Q15

Feltl & Co Downgrades Dollar Tree (DLTR) to Buy

September 2, 2015 9:19 AM EDT

Feltl & Co downgraded Dollar Tree (NASDAQ: DLTR) from Strong Buy to Buy.

For an analyst ratings summary and ratings history on Dollar Tree click here. For more ratings news on Dollar Tree click here.

Shares of Dollar Tree closed at $69.65 yesterday.

... More

Market Wrap: Markets Tumble on Continued China Fears; Google Debuts New Look; U.S. August Auto Sales Outpace

September 1, 2015 5:20 PM EDT

Market wrap for September 1st

End of the Day: S&P 500 down 58.3 to 1,913.85; Dow Jones down 469.7 to 16,858.35; Nasdaq down 140.4 to 4,636.10

Market Brief: Markets moved lower Tuesday following data showing China's PMI fell from 50.0 in July to 49.7 last month. The metric was the lowest reading since August 2012 and a number below 50. indicates contraction.

The ISM Manufacturing index slipped to 51.1 percent in August, missing expectations.

U.S. light-vehicle sales outpaced in August.

McDonald's is going to start offering breakfast all day. You read that... More

Dollar Tree sales miss as Family Dollar acquisition drags

September 1, 2015 12:18 PM EDT

By Subrat Patnaik

(Reuters) - Discount retailer Dollar Tree Inc's (NASDAQ: DLTR) quarterly sales rose less than analysts had expected as it focused on integrating Family Dollar stores amid intense competition from mass retailers such as Wal-Mart Stores Inc (NYSE: WMT).

Shares of the company, which also forecast current-quarter sales below Wall Street's estimates, fell as much as 8.6 percent to $69.68 in early trading on Tuesday.

Analysts had touted... More

Pre-Open Stock Movers 09/01: (TRVN) (KTOS) (ALKS) Higher; (ADEP) (DLTR) (GPRO) Lower (more...)

September 1, 2015 9:30 AM EDT

Trevena (NASDAQ: TRVN) 35.2% HIGHER; announced positive data from its randomized, double-blind, placebo- and active-controlled Phase 2b trial of TRV130 in moderate to severe acute postoperative pain after abdominoplasty surgery. The study achieved its primary endpoint of statistically greater pain reduction than placebo over 24 hours. In addition, TRV130 was superior to morphine in pre-specified secondary measures, exhibiting significantly reduced nausea, vomiting, and hypoventilation events.

Adept Technology (NASDAQ: ADEP)... More

Dollar Tree (DLTR) Misses Q2 EPS Views; Guides Q3, FY15 Revenue Below Expectations

September 1, 2015 7:35 AM EDT

Dollar Tree (Nasdaq: DLTR) reported Q2 EPS of $0.25, $0.37 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $3.01 billion versus the consensus estimate of $3.04 billion.

The increase was the result of $811.6 million in sales from the Family Dollar segment... More

Trading Radar for 9/1: Ambarella (AMBA) (Qihoo 360 (QIHU), Shoe Carnival (SCVL), AeroVironment (AVAV) Report

August 31, 2015 2:25 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Dollar Tree (Nasdaq: DLTR) - consensus EPS $0.62
Donaldson (NYSE: DCI) - consensus EPS $0.42
QIWI... More